Results 281 to 290 of about 73,485 (336)

Efficacy of Black Mulberry Mouthwash for Prevention of Chemotherapy-Induced Oral Mucositis: A Double-Blind Randomized Clinical Trial. [PDF]

Front Dent
Ghorbani A, Ghasemzadeh Z, Ghaffari Hamedani SMM, Akbari J, Moosazadeh M, Mirzaee F, Zamanzadeh M, Shahani S.   +7 more
europepmc   +1 more source

Graphene Oxide‐Based Gene Modulation in Preferential Elimination of Lung Cancer Cells in a 3D Tumor Microenvironment Model

Advanced NanoBiomed Research, Volume 5, Issue 7, July 2025.
Chemically modified graphene oxide nanocarriers provide a targeted lung cancer gene therapy platform. In a 3D tumor microenvironment model, these nanocarriers deliver therapeutic genes, regulate immune markers, and induce apoptosis in cancer cells. Combined gene delivery enhances cancer cell elimination, demonstrating the potential of this approach for
Francesca Grilli, Sadman Sakib, Fabio Variola, Shan Zou   +3 more
wiley   +1 more source

Mucosal immunity.

Nihon Naika Gakkai Zasshi, 1995
openaire   +3 more sources

Feasibility and population exposure of 5‐fluorouracil using therapeutic drug monitoring (PREDICT‐5FU): A multicentre clinical trial

British Journal of Clinical Pharmacology, Volume 91, Issue 7, Page 1965-1974, July 2025.
Aim PREDICT‐5FU aimed to document 5‐fluorouracil (5FU) exposure in a cancer population and to evaluate the feasibility of 5FU and capecitabine therapeutic drug monitoring (TDM) in patients receiving standard doses and schedules. Methods Multicentre, prospective, observational single‐arm study.
Sarah Glewis, Michael Michael, Howard Gurney, Ian Olver, Nicholas Zdenkowski, Stephen Ackland, Craig Kukard, Madawa Jayawardana, S. Sandun M. Silva, Marliese Alexander, Jeanne Tie, Peter Galettis, Jennifer H. Martin   +12 more
wiley   +1 more source

An in vitro study exploring a new method for managing peri-implant disease using the ten second technique. [PDF]

Sci Rep
De Nale M, Corte LD, Bruschi E, Visentin F.   +3 more
europepmc   +1 more source

A 5‐Year Follow‐Up Case Report Documenting Stable Peri‐Implant Health Status Around a Re‐Osseointegrated Implant

Clinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT This 5‐year follow‐up case report documents that local bone loss around an osseointegrated implant can be reversed and maintained stable, even in a medically compromised patient. Clinical and radiographical data indicate that the long‐term peri‐implant health status of a re‐osseointegrated implant can be maintained by reducing and/or ...
Kristian H. Lind, Einar Berg, Ingvild M. Ulvik, Knut N. Leknes   +3 more
wiley   +1 more source

Hospitalized Cancer Patients with Opioid Management for Chemo-Induced Ulcerative Mucositis Lessens the Patients' Overall Burden of Illness. [PDF]

Pharmaceuticals (Basel)
Mohan MP, Epstein JB, Meleveedu KS, Padhi P, Pili R, Satheeshkumar PS.   +5 more
europepmc   +1 more source

A Comprehensive Review on the Molecular Mechanism of Lycopene in Cancer Therapy

Food Science &Nutrition, Volume 13, Issue 7, July 2025.
This review highlights the molecular mechanism by which lycopene imparts its anticancerous role, focusing on clinical and animal trials to validate its effectiveness. The antioxidant profile of lycopene promotes anticancerous properties that reduce cancer prevalence by activating cell signaling pathways and gene expression (involved in cancer cell ...
Muhammad Maaz, Muhammad Tauseef Sultan, Muhammad Usman Khalid, Hassan Raza, Muhammad Imran, Muzzamal Hussain, Waleed Al Abdulmonem, Suliman A. Alsagaby, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Muhammad Asif Khan, Tadesse Fenta Yehuala, Samy Selim, Ehab M. Mostafa   +13 more
wiley   +1 more source

Co-occurrence of feline chronic gingivostomatitis and oral squamous cell carcinoma in 4 cats (2014-2024). [PDF]

Front Vet Sci
Tsugawa AJ, Soltero-Rivera MM, Goldschmidt S, Arzi B, Kell T, Hoyer N, Bell CM, Gao H, Shan G, Vapniarsky N.   +9 more
europepmc   +1 more source

The Efficacy and Safety of the Addition of Mitoxantrone Hydrochloride Liposome in Conditioning Regimen for High‐Risk Acute Myeloid Leukemia

Hematological Oncology, Volume 43, Issue 4, July 2025.
ABSTRACT Despite allo‐HSCT being the primary curative treatment for high‐risk AML, relapse‐free survival (RFS) remains suboptimal due to high relapse incidence. Our research focuses on optimizing the conditioning regimen by incorporating Mitoxantrone Hydrochloride Liposome (Lipo‐MIT), a novel nano‐formulation with enhanced pharmacokinetic properties ...
Xiaoyu Zhang, Donglin Yang, Aiming Pang, Sizhou Feng, Mingzhe Han, Yi He, Erlie Jiang   +6 more
wiley   +1 more source